細胞フリーヘモグロビンベースの血液代用品と心筋梗塞と死亡のリスク:メタ分析
Charles Natanson1, Steven J Kern, Peter Lurie
1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA. cnatanson@cc.nih.gov
JAMA
|April 30, 2008
まとめ
ヘモグロビンベースの血液代用品 (HBBS) は,患者にとってリスクが増加しています. 研究によると,これらの人工酸素運搬器を使用すると,死亡と心筋梗塞 (MI) の可能性が高いことが示されています.
科学分野:
- バイオメディカルエンジニアリング
- クリティカルケア・メディシン
- 血液学 ヘマトロジ
背景:
- ヘモグロビンベースの血液代用品 (HBBS) は,保存期間を延長し,冷蔵庫やクロスマッチングを必要としないなどの利点があります.
- HBBSは,特に遠隔地での出血性ショックの治療に考慮されています.
- 以前の試験では,明確な臨床的利益なしに,HBBSに関連したリスクの増加に関する懸念が高まっています.
研究 の 目的:
- ヘモグロビンベースの血液代用品 (HBBS) の安全性プロフィールを評価する.
- 手術,脳卒中,外傷患者の集団におけるHBBSのリスクを評価する.
主な方法:
- 1980年から2008年3月まで,PubMed,EMBASE,コクラン図書館の包括的な文献検索を実施しました.
- 19歳以上の患者におけるHBBSのランダム化比較試験 (RCT) を含む.
- 主要結果変数として死亡率と心筋梗塞 (MI) に関するデータを抽出.
主要な成果:
- 5種類のHBBS製品と3711人の患者を含む16件の試験を分析した.
- 治験の間で死亡率またはMIのアウトカムにおいて有意な異質性は見つかりませんでした (I2 = 0%).
- HBBSの使用で死亡リスク (RR,1.30; 95% CI,1.05-1.61) とMI (RR,2.71; 95% CI,1.67-4.40) の統計的に有意な増加が明らかになりました.
結論:
- ヘモグロビンベースの血液代用品 (HBBS) の使用は,死亡率の有意な増加と関連しています.
- HBBSは,心筋梗塞のリスクがかなり高まっていることも関連しています.
- これらの増加したリスクは,さまざまなHBBS製品と臨床用薬で観察されました.
関連する概念動画
Myocarditis I: Introduction
460
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
460
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
947
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
947
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
625
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
625
Blood Transfusion
2.5K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.5K
Blood Transfusion and Agglutination
15.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.0K


